Autosomal Recessive Polycystic Kidney Disease
📧 Sign up to get email alerts when something new happens for Autosomal Recessive Polycystic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study to See Iftolvaptan is Safe in Infants and Children Who at Enrollment Are 28 Days to Less Than 18 Years Old withAutosomal Recessive Polycystic Kidney Disease (ARPKD) [Phase 3]
Phase 3 clinical trial to evaluate the safety of Iftolvaptan in infants and children aged 28 days to under 18 years with autosomal recessive…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Imaging Assessments of ARPKD Kidney Disease Progression
This clinical trial update notes imaging-based assessments to monitor progression of autosomal recessive polycystic kidney disease (ARPKD) a…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: ARPKD Database Study
ClinicalTrials.gov entry indicates that the ARPKD Database Study sponsored by Children’s Hospital of Philadelphia is currently recruiting, a…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease in Children at Sohag University Hospital
This ClinicalTrials.gov entry describes a recruiting study at Sohag University Hospital investigating congenital hepatic fibrosis and autoso…